Osteocyte — A new target for the treatment of osteoporosis / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism
; (12): 627-630, 2013.
Article
in Zh
| WPRIM
| ID: wpr-437708
Responsible library:
WPRO
ABSTRACT
The osteocyte has been found to be an orchestrator of bone remodeling.The damage of bone leads to osteocyte apoptosis.Sclerostin secreted by osteocyte causes feedback inhibition of bone formation,so inhibition of sclerostin expression has become a new target of treatment for osteoporosis.It seems resonable to direct clinical practise and treatment of metabolic bone diseases through understanding the function of osteocyte in the process of bone remodeling.
Full text:
1
Database:
WPRIM
Language:
Zh
Journal:
Chinese Journal of Endocrinology and Metabolism
Year:
2013
Document type:
Article